I Feel Like I Got a Second Chance": An Engineer’s Journey with Bronchial Valves — A “True to Life” Story
February 25, 2026
Olympus Corporation (“Olympus”) has released the latest installment of its “True to Life Story” series, which highlights efforts that contribute to healthier and more fulfilling lives around the world through advanced medical technologies and solutions.
The latest story highlights Russ Welchert, a career engineer in the U.S.
Russ was diagnosed with Alpha-1 Antitrypsin Deficiency (AATD), a rare genetic condition that severely damaged his lungs and threatened his future. Through determination, long-term self-management, and bronchial valve treatment, he was able to breathe more freely and begin a new chapter of his life.
For the full story, please read the article here.
Olympus launched the global brand message "True to Life" in December 2021, and has been implementing various initiatives to raise its awareness as a global MedTech company and brand. As part of these initiatives, the company regularly publishes "True to Life Stories" in the form of videos and articles. To view the past stories, click the link below.
https://www.olympus-global.com/company/truetolife/stories/?page=company
* Products or devices presented include future technology which may be pending regional regulatory approval and are not available for sale in all regions.
* The contents in this website including products availability, specifications or prices are the information as of the date of announcement and are subject to change without prior notice.
* Information is intended to be presented to the media, shareholders, investors, and other interested parties. Information about our medical products (including products currently under development) included in this website is not intended for advertising or medical advice.
* Olympus Corporation assumes no responsibility for any damage resulting from the use of this material.
* All company names and product names mentioned in this website are trademarks or registered trademarks of their respective companies. All trademarks and registered trademarks are the property of their respective owners.